Status:
COMPLETED
The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
End Stage Renal Disease
Hemodialysis Complication
Eligibility:
All Genders
20-75 years
Phase:
PHASE1
Brief Summary
Written informed consent must be obtained before any study specific procedures are undertaken. Informed consent will be obtained during pre-operative assessment.
Detailed Description
The investigators will recruit 80 patients undergoing AV shunt surgery. All patients will receive general anesthesia and brachial plexus block. Patients will be randomly allocated into two groups. Stu...
Eligibility Criteria
Inclusion
- Uremic adult(over20-year-old)patients under going arteriovenous (AV) shunt surgery
Exclusion
- one of below systemic diseases; chronic pulmonary, cardiac diseases(such as COPD, asthma, acute myoischemia), hepatic co-mobility(such as liver cirrhosis), morbid obesity, alcoholism, allergy to propofol and inhaled anesthetics, the women who are pregnant or breastfeeding
Key Trial Info
Start Date :
September 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03311581
Start Date
September 11 2017
End Date
June 4 2021
Last Update
September 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan, 807